Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Ceyda Sonmez Wetherilt"'
Autor:
Shristi Bhattarai, Anurag Mehta, Uma Krishnamurti, Sergey Klimov, Elaine M. Walsh, Tiffany A. Traina, Brett Baskovich, Pooja K Gajaria, Atika Dogra, Xiaoxian Bill Li, Padmashree C.G. Rida, Guilherme Cantuaria, Ceyda Sonmez Wetherilt, Meenakshi V. Gupta, Haruna A Nggada, Ian O. Ellis, Tanuja Shet, Upender Manne, Grace Callagy, Saad A Ahmed, Mohammed A. Aleskandarany, Gabriela Oprea-Ilies, Ritu Aneja, Ansa Riaz, Johnson Agboola, Abidemi Omonisi, Karuna Mittal, Emiel A. M. Janssen, Emad A. Rakha, Andrew R. Green
Publikováno v:
Cancers, Vol 11, Iss 7, p 995 (2019)
Cancers
Cancers
Background: The androgen receptor (AR) has emerged as a potential therapeutic target for AR-positive triple-negative breast cancer (TNBC). However, conflicting reports regarding AR’s prognostic role in TNBC are putting its usefulness in question. S
Autor:
Tanuja Shet, Grace Callagy, Deepika Wali, Xiaoxian Bill Li, Ceyda Sonmez Wetherilt, Padmashree C.G. Rida, Upender Manne, Andrew R. Green, Mohammad A. Aleskandarany, Lauren E. McCullough, Johnson Agboola, Uma Krishnamurthi, Ritu Aneja, Ansa Riaz, Shristi Bhattarai, Meenakshi V. Gupta, Karuna Mittal, Ian O. Ellis, Anurag Mehta, Sergey Klimov, Brett Baskovich, Emiel A. M. Janssen, Rakha A. Emad
Publikováno v:
Cancer Epidemiology, Biomarkers & Prevention. 29:PR18-PR18
Background: African American (AA) triple-negative breast cancer (TNBC) patients experience worse clinical outcomes and exhibit 40% higher mortality rate than their European Americans (EAs) counterparts. There are currently no distinctions in inherent
Autor:
Sergey Klimov, Shristi Bhattarai, Arundhati Rao, Ceyda Sonmez Wetherilt, Remus Osan, Uma Krishnamurti, Chakravarthy Garlapati, Xiaoxian Bill Li, Padmashree C.G. Rida, Nikita Wright, Mildred Jones, Michelle D. Reid, Gabriela Oprea-Ilies, Ritu Aneja, Ansa Riaz, Meenakshi V. Gupta, Karuna Mittal, Ravi Chakra Turaga, Guilherme Cantuaria, Angela Ogden, Sonal Pattni
Publikováno v:
Scientific Reports
Nuclear KIFC1 (nKIFC1) predicts worse outcomes in breast cancer, but its prognostic value within racially distinct triple-negative breast cancer (TNBC) patients is unknown. Thus, nKIFC1 expression was assessed by immunohistochemistry in 163 African A
Publikováno v:
Human pathology. 64
Correlation between tumor-infiltrating lymphocytes (TILs) and complete pathological response (pCR) in breast cancers in neoadjuvant settings have been reported. In this study, we analyzed the association between TILs and diagnostic and prognostic par
Autor:
Emad A. Rakha, Meenakshi V. Gupta, Ceyda Sonmez Wetherilt, Shristi Bhattarai, Mohammad A. Aleskandaran, Guanhao Wei, Ian O. Ellis, Sergey Klimov, Xiaoxian Li, Ritu Aneja, Karuna Mittal, Remus Osan, Guilherme Cantuaria, Upender Manne, Padmashree C.G. Rida, Andrew A. Green, Uma Krishnamurthi
Publikováno v:
Cancer Epidemiology, Biomarkers & Prevention. 27:PR02-PR02
Background: Androgen receptor (AR) has emerged as a new target for treating TNBC. AR is expressed in 10-43% of TNBCs. Although there are conflicting reports in the literature about the effect of AR status on TNBC prognosis, agents targeting AR signal
Autor:
Jun Xia, Emad A. Rakha, Xiaoxian Li, Ceyda Sonmez Wetherilt, Sonal Pattni, Padmashree C.G. Rida, Remus Osan, Andrew R. Green, Ian O. Ellis, Mohammad A. Aleskandarany, Sergey Klimov, Uma Krishnamurthi, Bhattarai Shristi, Ritu Aneja, Ansa Riaz, Guilherme Cantuaria
Publikováno v:
Cancer Epidemiology, Biomarkers & Prevention. 26:B12-B12
Background: Triple Negative Breast Cancer (TNBC) is an aggressive subtype of breast cancer with high recurrence and mortality rates. Currently, there are no effective targeted therapies available for TNBC. Emerging data suggest that androgen receptor
Autor:
Sergey Klimov, Xiaoxian Li, Remus Osan, Uma Krishnamurti, Sonal Pattni, Guilherme Cantuaria, Jun Xia, Andrew R. Green, Ian O. Ellis, Shristi Bhattarai, Ceyda Sonmez Wetherilt, Mohammad A. Aleskandarany, Ritu Aneja, Padmashree C.G. Rida, Ansa Riaz, Emad A. Rakha
Publikováno v:
Journal of Clinical Oncology. 34:1089-1089
1089Background: Triple Negative Breast Cancer (TNBC) is a highly heterogeneous and aggressive breast carcinoma subtype typified by high recurrence and mortality rates. To date, no targeted therapie...
Autor:
Angela Ogden, Emad A. Rakha, Shristi Bhattarai, Ceyda Sonmez Wetherilt, Sonal Pattni, Uma Krishnamurti, Xiaoxian Li, Ian O. Ellis, Ritu Aneja, Padmashree C.G. Rida, Andrew R. Green, Nikita Wright, Michelle D. Reid, Sergey Klimov, Mohammad A. Aleskandarany
Publikováno v:
Journal of Clinical Oncology. 34:e12560-e12560
e12560Background: HER3 must heterodimerize with EGFR in triple-negative breast cancer (TNBC) to activate the oncogenic PI3K-Akt signaling pathway. PI3K-Akt signaling is often elevated in TNBCs, but compensatory HER3 and EGFR activation limits the eff